These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6440816)

  • 1. Ontogeny of the erythrocyte-dependent IgM antibody responses to cell membrane antigens.
    Saito M; Nakashima I; Mizoguchi K; Isobe K; Nagase F; Goto S; Tomoda Y; Kato N
    Dev Comp Immunol; 1984; 8(4):877-85. PubMed ID: 6440816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The donor cell type controls anti-hapten (fluorescein isothiocyanate) primary antibody response to hapten-modified syngeneic cells.
    Suzuki K; Nakashima I; Takashi M; Nagase F; Kato N; Isobe K; Mizoguchi K; Saito M
    Immunol Lett; 1982 Oct; 5(4):217-21. PubMed ID: 6816722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of primary IgM antibody responses to H-2 alloantigens by antigen-bearing live B lymphocytes.
    Nakashima I; Mizoguchi K; Kato N; Nagase F; Isobe K; Saito M; Suzuki K
    Eur J Immunol; 1982 Sep; 12(9):713-9. PubMed ID: 6216113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical effects of LPS on the T-cell-independent type 2 anti-H-2 alloantigen antibody responses to allogeneic erythrocytes.
    Mizoguchi K; Nakashima I; Isobe KI; Saito M; Nagase F; Kato N; Shimokata K
    Transplantation; 1984 Jan; 37(1):101-5. PubMed ID: 6607555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the erythrocyte as the principal antigenic cell type that triggers primary IgM antibody responses to H-2D alloantigens.
    Nakashima I; Clark EA; Lake P; Kato N; Nagase F; Mizoguchi K; Isobe KI; Saito M
    Transplantation; 1983 Feb; 35(2):180-4. PubMed ID: 6600860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface structures required for B-cell activation with haptenated syngeneic cells.
    Ramos T
    Scand J Immunol; 1983 May; 17(5):411-7. PubMed ID: 6407098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary antibody responses to hapten-modified syngeneic cells: exceptional immunogenicity of erythrocytes.
    Nakashima I; Takashi M; Nagase F; Kato N
    Eur J Immunol; 1981 Nov; 11(11):946-8. PubMed ID: 6799301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen presentation by hapten-specific B lymphocytes. V. Requirements for activation of antigen-presenting B cells.
    Liano D; Abbas AK
    J Immunol; 1987 Oct; 139(8):2562-6. PubMed ID: 2958554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-mediated suppression of the immune response is determinant specific.
    Möller G
    Eur J Immunol; 1985 Apr; 15(4):409-12. PubMed ID: 2580716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrancy in immunogenicity and cell-surface expression of H-2 antigens on erythrocytes.
    Nakashima I; Yoshida T; Yokochi T; Ohashi K; Nagase F; Isobe K; Hasegawa Y; Ando K; Inagi R
    Immunogenetics; 1986; 24(1):32-40. PubMed ID: 3488270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory function of Thy1-negative cells. I.--Evidence for cells without the Thy1-surface marker and without phagocytic properties, enhancing the IgM antibody response.
    Del Guercio P; Poirier MF; Brugère S
    Ann Immunol (Paris); 1982; 133C(1):119-31. PubMed ID: 6178353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the clonal diversity of the B cell repertoires in adult mice that differ in the expression of cell surface IgD.
    Fultz MJ; Finkelman FD; Metcalf ES
    Eur J Immunol; 1987 Aug; 17(8):1137-43. PubMed ID: 3113979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three B-cell-surface molecules associating with membrane immunoglobulin.
    Parkhouse RM
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():741-4. PubMed ID: 2518009
    [No Abstract]   [Full Text] [Related]  

  • 14. The stimulation of T cells with anti-CD2 monoclonal antibodies facilitates the induction of polyclonal B-cell responses but does not enhance the activation of antigen-specific B cells.
    Trifiletti R; Hyman B; LaVia M; Knapp W; Virella G
    Scand J Immunol; 1990 Jan; 31(1):25-31. PubMed ID: 1689073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyclonal B cell activation by B cell differentiation factor B151-TRF2. I. Involvement of self-Ia recognition process mediated by B cells.
    Ono S; Takahama Y; Hamaoka T
    J Immunol; 1986 Aug; 137(4):1149-56. PubMed ID: 3090140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characteristics of Peyer's patch lymphoid cells. II. Lipopolysaccharide is thymus dependent.
    Kagnoff MF; Billings P; Cohn M
    J Exp Med; 1974 Feb; 139(2):407-13. PubMed ID: 4589992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hierarchy of cytotoxic T cell clones. II. Intraclonal triggering of lysis by hapten-specific CTL.
    Skinner M; Hartley L; Marbrook J
    Cell Immunol; 1989 Sep; 122(2):471-82. PubMed ID: 2504498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The production and radioimmunoassay application of monoclonal antibodies to fluorescein isothiocyanate (FITC).
    Micheel B; Jantscheff P; Böttger V; Scharte G; Kaiser G; Stolley P; Karawajew L
    J Immunol Methods; 1988 Jun; 111(1):89-94. PubMed ID: 3134489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The failure to show a necessary role for C3 in the in vitro antibody response.
    Waldmann H; Lachmann PJ
    Eur J Immunol; 1975 Mar; 5(3):185-93. PubMed ID: 1086224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier-directed anti-hapten responses by B-cell subsets.
    Lewis GK; Goodman JW
    J Exp Med; 1977 Jul; 146(1):1-10. PubMed ID: 68986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.